Jane Street Group, LLC Alaunos Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.5 $1,516 - $6,320	12,641 New	12,641 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $261.0 $70,599 - $36.9 Million	141,198 New	141,198 $91,000
Q2 2022 Aug 16, 2022	BUY	$0.41 - $1.24 $34,029 - $102,918	82,999 Added 289.72%	111,647 $138,000
Q1 2022 May 17, 2022	SELL	$0.62 - $1.17 $13,926 - $26,280	-22,462 Reduced 43.95%	28,648 $19,000
Q4 2021 Feb 15, 2022	BUY	$1.09 - $1.89 $44,676 - $77,467	40,988 Added 404.94%	51,110 $56,000
Q3 2021 Nov 16, 2021	SELL	$1.44 - $2.73 $125,975 - $238,828	-87,483 Reduced 89.63%	10,122 $19,000
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $113,155 - $157,901	43,025 Added 78.83%	97,605 $258,000
Q1 2021 May 18, 2021	BUY	$2.82 - $5.6 $54,256 - $107,744	19,240 Added 54.44%	54,580 $196,000
Q4 2020 Feb 17, 2021	SELL	$2.09 - $3.09 $186,099 - $275,142	-89,043 Reduced 71.59%	35,340 $89,000
Q3 2020 Nov 17, 2020	BUY	$2.39 - $3.43 $17,870 - $25,646	7,477 Added 6.4%	124,383 $314,000
Q2 2020 Aug 17, 2020	BUY	$2.2 - $3.71 $217,349 - $366,529	98,795 Added 545.5%	116,906 $383,000
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $5,453 - $14,292	2,870 Added 18.83%	18,111 $44,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $103,794 - $140,581	-26,277 Reduced 63.29%	15,241 $72,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $171,469 - $288,134	41,518 New	41,518 $177,000
Q1 2019 May 16, 2019	SELL	$2.0 - $4.4 $222,448 - $489,385	-111,224 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.61 - $3.62 $98,229 - $220,863	61,012 Added 121.51%	111,224 $208,000
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $89,258 - $129,148	39,495 Added 368.53%	50,212 $161,000
Q4 2017 Feb 15, 2018	SELL	$4.0 - $6.54 $69,592 - $113,782	-17,398 Reduced 61.88%	10,717 $44,000
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $140,293 - $184,715	28,115	28,115 $173,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account